Certifications & Licenses
Grafix® is a cryopreserved placental allograft tissue for acute and chronic wounds. Grafix is regulated as a human cells, tissue, or a cellular or tissue-based product (HCT/P) under 21 CFR part 1271 and section 361 of the Public Health Service (PHS) Act.
About Osiris Therapeutics
Osiris Therapeutics, Inc. is registered with the FDA as a tissue establishment and accredited by the American Association of Tissue Banks (AATB).
Take Your First Step in a New DirectionTo learn more about Grafix, or to place an order, please contact us directly.
7015 Albert Einstein Drive
Columbia, MD 21046
Customer Service: (888) 674-9551
Fax: (443) 283-4419
For general product information or to place an order, contact: Biosurgery@osiris.com
Published Data - Downloads
- Robert G Frykberg, Gary W Gibbons, Jodi L Walters, Dane K Wukich, Farrell C Milstein A prospective, multicentre, open-label, single-arm clinical trial for treatment of chronic complex diabetic foot wounds with exposed tendon and/or bone: positive clinical outcomes of viable cryopreserved human placental membrane
- Lavery LA, Fulmer J, Shebetka KA, Regulski M, Vayser D, Fried D, et al. The efficacy and safety of Grafix for the treatment of chronic diabetic foot ulcers.
- Regulski M, Jacobstein DA, Petranto RD, Migliori VJ, Nair G, Pfeiffer D. A retrospective analysis of a human cellular repair matrix for the treatment of chronic wounds.
For medical information, contact: Medicalinformation@osiris.com